GeneDx Holdings's market cap is currently ―. The company's EPS TTM is $-5.246; its P/E ratio is -4.46; GeneDx Holdings is scheduled to report earnings on August 12, 2024, and the estimated EPS forecast is $-0.48. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 62.42M	$ 53.30M	$ 48.71M	$ 43.14M	-
Gross Profit	$ 37.41M	$ 25.26M	$ 17.70M	$ 13.49M	-
EBIT	$ -19.72M	$ -43.51M	$ -46.29M	$ -57.65M	-
EBITDA	$ -19.72M	-	$ -46.16M	$ -57.52M	-
Net Income Common Stockholders	$ -20.24M	$ -42.29M	$ -46.72M	$ -60.99M	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 112.91M	$ 114.30M	$ 156.66M	$ 214.04M	$ 137.37M
Total Assets	$ 394.53M	$ 417.29M	$ 476.39M	$ 545.30M	$ 490.91M
Total Debt	$ 52.29M	$ 6.05M	$ 6.25M	$ 6.25M	$ 6.25M
Net Debt	$ -60.62M	$ -108.25M	$ -150.41M	$ -207.79M	$ -131.12M
Total Liabilities	$ 187.31M	$ 163.03M	$ 180.28M	$ 216.83M	$ 237.24M
Stockholders Equity	$ 207.22M	$ 254.26M	$ 296.11M	$ 328.47M	$ 253.71M
Cash Flow	-
Free Cash Flow	$ -16.86M	-	$ -52.65M	$ -55.56M	-
Operating Cash Flow	$ -16.41M	$ -41.23M	$ -53.52M	$ -55.56M	-
Investing Cash Flow	$ 843.00K	$ -27.13M	$ -11.27M	$ -462.00K	-
Financing Cash Flow	$ -438.00K	$ -911.00K	$ 7.39M	$ 132.66M	-

Currency in USD

GeneDx Holdings Earnings and Revenue History

Income Statement >

GeneDx Holdings Debt to Assets

Balance Sheet >

GeneDx Holdings Cash Flow

Cash Flow >

GeneDx Holdings Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing